시장보고서
상품코드
1261890

세계의 생물제제 시장 리포트(2023년)

Biologics Global Market Report 2023

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 400 Pages | 배송안내 : 2-10일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

생물제제 세계 시장은 2022년 3,820억 4,000만 달러에서 2023년에는 4,166억 5,000만 달러로, CAGR 9.1%로 성장할 것으로 예측됩니다. 러시아 우크라이나 전쟁은 적어도 단기적으로 COVID-19 팬데믹으로부터의 세계 경제 회복 가능성을 혼란시켰습니다. 이 두 국가 간의 전쟁은 여러 국가에 대한 경제 제재, 상품 가격 상승, 공급망 혼란으로 이어져 전세계 많은 시장에 영향을 미칩니다. 생물제제 시장은 CAGR 9.5%로 2027년에 5,996억 2,000만 달러에 이를 것으로 예상됩니다.

2022년 생물제제 시장에서는 북미가 최대 지역이 되었습니다. 중동은 예측 기간 동안 가장 빠르게 성장하는 지역이 될 전망입니다. 생물제제 시장 보고서의 대상 지역은 아시아태평양, 서유럽, 동유럽, 북미, 남미, 중동 및 아프리카입니다.

목차

제1장 주요 요약

제2장 보고서 구조

제3장 생물제제 시장의 특징

  • 시장의 정의
  • 주요 세분화

제4장 생물제제 시장의 제품 분석

  • 주요 제품·서비스
  • 주요 기능과 차별화 요인
  • 개발품

제5장 생물제제 시장의 공급망

  • 공급망
  • 유통
  • 최종 고객

제6장 생물제제 시장 고객 정보

  • 고객의 선호
  • 최종 용도의 시장 규모와 성장

제7장 생물제제 시장의 동향과 전략

제8장 생물제제 시장 - 매크로 경제 시나리오

  • 생물제제 시장에 대한 COVID-19의 영향
  • 우크라이나와 러시아의 전쟁이 생물제제 시장에 미치는 영향
  • 생물제제 시장에 대한 고인플레이션의 영향

제9장 생물제제의 시장 규모와 성장

  • 시장 규모
  • 시장 성장 실적
    • 시장의 촉진요인
    • 시장의 억제요인
  • 시장 성장 예측
    • 시장의 촉진요인
    • 시장의 억제요인

제10장 생물제제 시장의 지역 분석

  • 세계의 생물제제 시장, 2022년, 지역별
  • 세계의 생물제제 시장, 2017-2022, 2022-2027F, 2032F, 실적과 예측, 지역별
  • 지역별 세계의 생물제제 시장, 성장과 시장 점유율의 비교

제11장 생물제제 시장 세분화

  • 세계의 생물제제 시장, 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 단클론항체(MAbS)
  • 치료용 단백질
  • 백신
  • 세계의 생물제제 시장, 유통 채널별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 병원 약국
  • 약국·드럭스토어
  • 기타
  • 세계의 생물제제 시장, 투여 경로별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 경구
  • 비경구
  • 기타
  • 세계의 생물제제 시장, 약물 분류별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 브랜드 의약품
  • 제네릭 의약품
  • 세계의 생물제제 시장, 구매 모드별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 처방약
  • 시판약

제12장 생물제제 시장 부문

  • 세계의 단클론항체(MAbS) 시장, 유형별 세분화, 2017-2022, 2022-2027F, 2032F
  • 세계의 치료용 단백질 시장, 유형별 세분화, 2017-2022, 2022-2027F, 2032F
  • 세계의 백신 시장, 유형별 세분화, 2017-2022, 2022-2027F, 2032F

제13장 생물제제 시장 지표

  • 생물제제의 시장 규모, GDP의 비율, 2017-2027년, 세계
  • 1인당 평균 생물제제 시장 지출, 2017-2027년, 세계

제14장 아시아태평양 생물제제 시장

  • 아시아태평양 생물제제 시장 개요
  • 지역 정보, COVID-19의 영향, 시장 정보, 배경 정보, 정부의 이니셔티브, 규제, 규제 기관, 주요 단체, 과세되는 세, 법인세 구조, 투자, 주요 기업
  • 아시아태평양, 생물제제 시장, 2022년, 국가별
  • 아시아태평양, 생물제제 시장, 2017-2022, 2022-2027F, 2032F, 실적과 예측, 국가별
  • 아시아태평양, 생물제제 시장, 2017-2022년, 2022-2027F, 2032F, 국가별 성장과 시장 점유율의 비교
  • 아시아태평양, 생물제제 시장 지표
    • 1인당 평균 생물제제 지출, 2017-2027년, 아시아태평양 국가
    • 기업 수, 생물제제 시장, 생물제제 시장 / 기업 수, 2022년, 아시아태평양 국가
    • 종업원 수, 생물제제 시장, 생물제제 시장 / 종업원 수, 2022, 아시아태평양 국가
  • 아시아태평양 생물제제 시장, 유형별 세분화, 2017-2022, 2022-2027F, 2032F
  • 아시아태평양 생물제제 시장 : 국가별 분석
    • 중국 생물제제 시장
    • 호주 생물제제 시장
    • 홍콩 생물제제 시장
    • 인도의 생물제제 시장
    • 인도네시아 생물제제 시장
    • 일본의 생물제제 시장
    • 말레이시아의 생물제제 시장
    • 뉴질랜드의 생물제제 시장
    • 필리핀 생물제제 시장
    • 싱가포르 생물제제 시장
    • 한국의 생물제제 시장
    • 태국의 생물제제 시장
    • 베트남 생물제제 시장
    • 방글라데시의 생물제제 시장

제15장 서유럽의 생물제제 시장

  • 서유럽의 생물제제 시장 개요
  • 서유럽, 생물제제 시장, 2022년, 국가별
  • 서유럽, 생물제제 시장, 2017-2022, 2022-2027F, 2032F, 실적과 예측, 국가별
  • 서유럽, 생물제제 시장, 2017-2022년, 2022-2027F, 2032F, 국가별 성장과 시장 점유율의 비교
  • 서유럽, 생물제제 시장 지표
    • 1인당 평균 생물제제 지출, 2017-2027년, 서유럽 국가
    • 기업 수, 생물제제 시장, 생물제제 시장 / 기업 수, 2022년, 서유럽 국가
    • 종업원 수, 생물제제 시장, 생물제제 시장 / 종업원 수, 2022년, 서유럽 국가
  • 서유럽의 생물제제 시장, 유형별 세분화, 2017-2022, 2022-2027F, 2032F
  • 서유럽의 생물제제 시장 : 국가별 분석
    • 오스트리아 생물제제 시장
    • 벨기에 생물제제 시장
    • 덴마크 생물제제 시장
    • 핀란드 생물제제 시장
    • 프랑스 생물제제 시장
    • 독일 생물제제 시장
    • 아일랜드 생물제제 시장
    • 이탈리아 생물제제 시장
    • 네덜란드의 생물제제 시장
    • 노르웨이 생물제제 시장
    • 포르투갈의 생물제제 시장
    • 스페인 생물제제 시장
    • 스웨덴의 생물제제 시장
    • 스위스의 생물제제 시장
    • 영국의 생물제제 시장

제16장 동유럽의 생물제제 시장

  • 동유럽의 생물제제 시장 개요
  • 동유럽, 생물제제 시장, 2022년, 국가별
  • 동유럽, 생물제제 시장, 2017-2022, 2022-2027F, 2032F, 실적과 예측, 국가별
  • 동유럽, 생물제제 시장, 2017-2022, 2022-2027F, 2032F, 국가별 성장과 시장 점유율의 비교
  • 동유럽, 생물제제 시장의 지표
    • 1인당 평균 생물제제 지출, 2017-2027년, 동유럽 국가
    • 기업 수, 생물제제 시장, 생물제제 시장 / 기업 수, 2022년, 동유럽 국가
    • 종업원 수, 생물제제 시장, 생물제제 시장 / 종업원 수, 2022년, 동유럽 국가
  • 동유럽의 생물제제 시장, 유형별 세분화, 2017-2022, 2022-2027F, 2032F
  • 동유럽의 생물제제 시장 : 국가별 분석
    • 체코 공화국 생물제제 시장,
    • 폴란드의 생물제제 시장
    • 루마니아 생물제제 시장
    • 러시아의 생물제제 시장
    • 우크라이나의 생물제제 시장

제17장 북미 생물제제 시장

  • 북미 생물제제 시장 개요
  • 북미, 생물제제 시장, 2022년, 국가별
  • 북미, 생물제제 시장, 2017-2022, 2022-2027F, 2032F, 국가별 실적과 예측
  • 북미, 생물제제 시장, 2017-2022, 2022-2027F, 2032F, 국가별 성장과 시장 점유율의 비교
  • 북미, 생물제제 시장의 지표
    • 1인당 평균 생물제제 지출, 2017-2027년, 북미 국가
    • 기업 수, 생물제제 시장, 생물제제 시장 / 기업 수, 2022년, 북미 국가
    • 종업원 수, 생물제제 시장, 생물제제 시장 / 종업원 수, 2022년, 북미 국가
  • 북미 생물제제 시장, 유형별 세분화, 2017-2022, 2022-2027F, 2032F
  • 북미 생물제제 시장 : 국가별 분석
    • 캐나다의 생물제제 시장
    • 멕시코 생물제제 시장
    • 미국 생물제제 시장

제18장 남미 생물제제 시장

  • 남미 생물제제 시장 개요
  • 남미, 생물제제 시장, 2022년, 국가별
  • 남미, 생물제제 시장, 2017-2022, 2022-2027F, 2032F, 국가별 실적과 예측
  • 남미, 생물제제 시장, 2017-2022, 2022-2027F, 2032F, 국가별 성장과 시장 점유율의 비교
  • 남미, 생물제제 시장의 지표
    • 1인당 평균 생물제제 지출, 2017-2027년, 남미 국가
    • 기업 수, 생물제제 시장, 생물제제 시장/기업 수, 2022년, 남미 국가
    • 종업원 수, 생물제제 시장, 생물제제 시장 / 종업원 수, 2022년, 남미 국가
  • 남미의 생물제제 시장, 유형별 세분화, 2017-2022, 2022-2027F, 2032F
  • 남미 생물제제 시장 : 국가별 분석
    • 아르헨티나 생물제제 시장
    • 브라질 생물제제 시장
    • 칠레 생물제제 시장
    • 콜롬비아 생물제제 시장
    • 페루의 생물제제 시장
    • 베네수엘라 생물제제 시장

제19장 중동 생물제제 시장

  • 중동 생물제제 시장 개요
  • 중동, 생물제제 시장, 2022년, 국가별
  • 중동, 생물제제 시장, 2017-2022, 2022-2027F, 2032F, 실적과 예측, 국가별
  • 중동, 생물제제 시장, 2017-2022년, 2022-2027F, 2032F, 국가별 성장과 시장 점유율의 비교
  • 중동, 생물제제 시장의 지표
    • 1인당 평균 생물제제 지출, 2017-2027년, 중동 국가
    • 기업 수, 생물제제 시장, 생물제제 시장 / 기업 수, 2022년, 중동 국가
    • 종업원 수, 생물제제 시장, 생물제제 시장 / 종업원 수, 2022, 중동 국가
  • 중동 생물제제 시장, 유형별 세분화, 2017-2022, 2022-2027F, 2032F
  • 중동 생물제제 시장 : 국가별 분석
    • 사우디아라비아의 생물제제 시장
    • 이스라엘 생물제제 시장
    • 터키의 생물제제 시장
    • 아랍에미리트(UAE)의 생물제제 시장

제20장 아프리카 생물제제 시장

  • 아프리카 생물제제 시장 개요
  • 아프리카, 생물제제 시장, 2022년, 국가별
  • 아프리카, 생물제제 시장, 2017-2022, 2022-2027F, 2032F, 실적과 예측, 국가별
  • 아프리카, 생물제제 시장, 2017-2022, 2022-2027F, 2032F, 성장과 시장 점유율 비교, 국가별
  • 아프리카, 생물제제 시장 지표
    • 1인당 평균 생물제제 지출, 2017-2027년, 아프리카 국가
    • 기업 수, 생물제제 시장, 생물제제 시장 / 기업 수, 2022년, 아프리카 국가
    • 종업원 수, 생물제제 시장, 생물제제 시장 / 종업원 수, 2022년, 아프리카 국가
  • 아프리카 생물제제 시장, 유형별 세분화, 2017-2022, 2022-2027F, 2032F
  • 아프리카의 생물제제 시장 : 국가별 분석
    • 이집트 생물제제 시장
    • 나이지리아 생물제제 시장
    • 남아프리카공화국의 생물제제 시장

제21장 생물제제 시장의 경쟁 상황

  • 경쟁 시장 개요
  • 시장 점유율
  • 기업 개요
    • AbbVie
    • Johnson &Johnson
    • Amgen
    • Sanofi SA
    • F. Hoffmann-La Roche Ltd

제22장 생물제제 시장에서 주요 합병과 인수

제23장 시장 배경: 의약품 시장

  • Pharmaceuticals Market Characteristics
  • Pharmaceuticals Market Historic and Forecast, 2017-2022, 2022-2027F, 2032F Growth, By Segment
  • Global Pharmaceuticals Market, 2022, By Region
  • Global Pharmaceuticals Market, 2017-2022, 2022-2027F, 2032F, Historic And Forecast, By Region
  • Global Pharmaceuticals Market, 2017-2022, 2022-2027F, 2032F, Segmentation By Type

제24장 권장사항

  • 2027년 세계의 생물제제 시장 - 성장 국가
  • 2027년 세계 생물제제 시장 - 성장 부문
  • 2027년 세계의 생물제제 시장 - 성장 전략

제25장 부록

ksm 23.05.04

“Biologics Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biologics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biologics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The biologics market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Monoclonal Antibodies (MAbS); Therapeutic Proteins; Vaccines
  • 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Other Distribtuion Channels
  • 3) By Route Of Administration: Oral; Parenteral; Other Route Of Administration
  • 4) By Drug Classification: Branded Drugs; Generic Drugs
  • 5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs
  • Subsegments Covered: Anti-Cancer MAbS; Immunological MAbS; Anti-Infective Monoclonal Antibodies (MAbs); Neuropharmacological MABS; Cardiovascular And Cerebrovascular MAbS; Other Monoclonal Antibodies (MAbs); Metabolic Disorders Therapeutic Proteins; Cancer Therapeutic Proteins; Cardiovascular Therapeutic Proteins; Immunological Therapeutic Proteins; Other Therapeutic Proteins; Anti-Infective Vaccines; Autoimmunity Vaccines; Other Vaccines
  • Companies Mentioned: AbbVie; Johnson & Johnson; Amgen; Sanofi S.A; F. Hoffmann-La Roche Ltd.
  • Countries: Australia, China, Bangladesh, India, Indonesia, Japan, South Korea, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, USA, Canada, Mexico, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major companies in the biologics market include: AbbVie, Johnson & Johnson, Amgen, Sanofi S.A, F. Hoffmann-La Roche Ltd., GlaxosmithKline, Novartis AG, Pfizer Inc., Teva Pharmaceuticals and CSL.

The global biologics market is expected to grow from $382.04 billion in 2022 to $416.65 billion in 2023 at a compound annual growth rate (CAGR) of 9.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, and affecting many markets across the globe. The biologics market is expected to reach $599.62 billion in 2027 at a CAGR of 9.5%.

The biologics market consists of sales of Tumor necrosis factor inhibitors, Interleukin inhibitors, B-cells inhibitors, and T-cells inhibitors. Values in this market are: 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Biologics are medications made from organic materials that can be used to treat a wide range of illnesses, and they are frequently used to treat immune-related illnesses such Crohn's disease, psoriasis, ankylosing spondylitis, and rheumatoid arthritis. The interesting aspect is that biologics are separated from various natural sources, whether they be carbohydrates, proteins, nucleic acids, or a complex mixture of these materials.

North America was the largest region in the biologics market in 2022. Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main types of biologics are monoclonal antibodies (MAbs), therapeutic proteins, and vaccines. Monoclonal antibodies, or mAbs, are created in a laboratory to combat a specific infection. The various route of administration includes oral, parenteral, and others that are distributed by hospital pharmacies, retail pharmacies/ drug stores, and others.

Technology is expected to be a continued driver of market growth during this period. An area of particular development is likely to be physiology simulation modeling. Markets such as this one will benefit from the greater efficiencies offered by developments in this area. For example, Eli Lilly and Pfizer have adopted Amazon's Elastic Compute Cloud (EC2) platform to conduct simulation models in early drug discovery that have been operational within hours, whereas traditional models would have taken weeks to conduct simulations. The Open Innovation Drug Discovery program is another initiative by Lilly to enhance the research and development of biologics. Such technological advances are likely to reduce costs and expedite the development phase of biologics, allowing companies to launch their products early.

The early generation of biologics is losing its patent protection and is expected to face greater competition going forward from the entry of biosimilars into the market. Biosimilars are pharmaceuticals that are developed to have similar properties to a biological drug that has already been approved. Demand for biosimilars is being fueled by governments around the world trying to reduce healthcare costs. In India, a new biosimilar policy called the 'Guidelines on Similar Biologics' prepared by the Central Drugs Standard Control Organization (CSDCO) is expected to give a major boost to the Indian biosimilars industry. In the EU, a pathway for approving biosimilar medicines has existed since 2003. These less expensive alternatives increase the competitiveness of the biologics market putting downward pressure on pricing and market value growth.

The US Food and Drug Administration (FDA) has revised its regulations to eliminate outdated biologics requirements, thus allowing drug manufacturers to employ new manufacturing technologies and testing capabilities. Standard preparations (standard solutions containing a precisely known concentration of an element), which help to ensure the safety, purity, and potency of biologics can now be obtained from sources other than FDA's Center for Biologics Evaluation and Research (CBER) or can be developed internally by the biologics license applicant. The FDA has also removed a rule (Section 610.21 of FDA code) that specifies minimal potency limits to be met for certain antibodies and antigens. In addition, FDA is also updating regulations (Section 610.53 of FDA code) regarding storage periods and storage conditions for biologics. These amendments in regulations are expected to increase regulatory flexibility by allowing the pharmaceutical industry and the FDA to incorporate current scientific technologies in the manufacture of licensed biological products.

The countries covered in the biologics market report are: Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela and Vietnam. 

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The biologics market research report is one of a series of new reports from The Business Research Company that provides biologics market statistics, including biologics industry global market size, regional shares, competitors with a biologics market share, detailed biologics market segments, market trends, and opportunities, and any further data you may need to thrive in the biologics industry. This biologics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Table of Contents

1. Executive Summary

2. Report Structure

3. Biologics Market Characteristics

  • 3.1. Market Definition
  • 3.2. Key Segmentations

4. Biologics Market Product Analysis

  • 4.1. Leading Products/ Services
  • 4.2. Key Features and Differentiators
  • 4.3. Development Products

5. Biologics Market Supply Chain

  • 5.1. Supply Chain
  • 5.2. Distribution
  • 5.3. End Customers

6. Biologics Market Customer Information

  • 6.1. Customer Preferences
  • 6.2. End Use Market Size and Growth

7. Biologics Market Trends And Strategies

8. Biologics Market - Macro Economic Scenario

  • 8.1 COVID-19 Impact On Biologics Market
  • 8.2 Ukraine-Russia War Impact On Biologics Market
  • 8.3 Impact Of High Inflation On Biologics Market

9. Biologics Market Size And Growth

  • 9.1. Market Size
  • 9.2. Historic Market Growth, Value ($ Billion)
    • 9.2.1. Drivers Of The Market
    • 9.2.2. Restraints On The Market
  • 9.3. Forecast Market Growth, Value ($ Billion)
    • 9.3.1. Drivers Of The Market
    • 9.3.2. Restraints On The Market

10. Biologics Market Regional Analysis

  • 10.1. Global Biologics Market, 2022, By Region, Value ($ Billion)
  • 10.2. Global Biologics Market, 2017-2022, 2022-2027F, 2032F, Historic And Forecast, By Region
  • 10.3. Global Biologics Market, Growth And Market Share Comparison, By Region

11. Biologics Market Segmentation

  • 11.1. Global Biologics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Monoclonal Antibodies (MAbS)
  • Therapeutic Proteins
  • Vaccines
  • 11.2. Global Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies/ Drug Stores
  • Others
  • 11.3. Global Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Oral
  • Parenteral
  • Others
  • 11.4. Global Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Branded Drugs
  • Generic Drugs
  • 11.5. Global Biologics Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Prescription-Based Drugs
  • Over-The-Counter Drugs

12. Biologics Market Segments

  • 12.1. Global Monoclonal Antibodies (MAbS) Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion) - Anti-Cancer MAbS; Immunological MAbS; Anti-Infective Monoclonal Antibodies (MAbs); Neuropharmacological MABS; Cardiovascular And Cerebrovascular MAbS; Other Monoclonal Antibodies (MAbs)
  • 12.2. Global Therapeutic Proteins Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion) - Metabolic Disorders Therapeutic Proteins; Cancer Therapeutic Proteins; Cardiovascular Therapeutic Proteins; Immunological Therapeutic Proteins; Other Therapeutic Proteins
  • 12.3. Global Vaccines Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion) - Anti-Infective Vaccines; Autoimmunity Vaccines; Other Vaccines

13. Biologics Market Metrics

  • 13.1. Biologics Market Size, Percentage Of GDP, 2017-2027, Global
  • 13.2. Per Capita Average Biologics Market Expenditure, 2017-2027, Global

14. Asia-Pacific Biologics Market

  • 14.1. Asia-Pacific Biologics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Asia-Pacific, Biologics Market, 2022, By Country, Value ($ Billion)
  • 14.3. Asia-Pacific, Biologics Market, 2017-2022, 2022-2027F, 2032F, Historic And Forecast, By Country
  • 14.4. Asia-Pacific, Biologics Market, 2017-2022, 2022-2027F, 2032F, Growth And Market Share Comparison, By Country
  • 14.5. Asia-Pacific, Biologics Market Metrics
    • 14.5.1. Per Capita Average Biologics Expenditure, 2017-2027, Asia-Pacific Countries
    • 14.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2022, Asia-Pacific Countries
    • 14.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2022, Asia-Pacific Countries
  • 14.6. Asia-Pacific Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 14.7. Asia-Pacific Biologics Market: Country Analysis
    • 14.7.1. China Biologics Market
      • 14.7.1.1. China Biologics Market Overview
      • 14.7.1.2. China Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
      • 14.7.1.3. China Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 14.7.2. Australia Biologics Market
      • 14.7.2.1. Australia Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
      • 14.7.2.2. Australia Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 14.7.3. Hong Kong Biologics Market
      • 14.7.3.1. Hong Kong Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 14.7.4. India Biologics Market
      • 14.7.4.1. India Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
      • 14.7.4.2. India Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 14.7.5. Indonesia Biologics Market
      • 14.7.5.1. Indonesia Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
      • 14.7.5.2. Indonesia Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 14.7.6. Japan Biologics Market
      • 14.7.6.1. Japan Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
      • 14.7.6.2. Japan Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 14.7.7. Malaysia Biologics Market
      • 14.7.7.1. Malaysia Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 14.7.8. New Zealand Biologics Market
      • 14.7.8.1. New Zealand Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 14.7.9. Philippines Biologics Market
      • 14.7.9.1. Philippines Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 14.7.10. Singapore Biologics Market
      • 14.7.10.1. Singapore Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 14.7.11. South Korea Biologics Market
      • 14.7.11.1. South Korea Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
      • 14.7.11.2. South Korea Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 14.7.12. Thailand Biologics Market
      • 14.7.12.1. Thailand Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 14.7.13. Vietnam Biologics Market
      • 14.7.13.1. Vietnam Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 14.7.14. Bangladesh Biologics Market
      • 14.7.14.1. Bangladesh Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)

15. Western Europe Biologics Market

  • 15.1. Western Europe Biologics Market Overview
  • 15.2. Western Europe, Biologics Market, 2022, By Country, Value ($ Billion)
  • 15.3. Western Europe, Biologics Market, 2017-2022, 2022-2027F, 2032F, Historic And Forecast, By Country
  • 15.4. Western Europe, Biologics Market, 2017-2022, 2022-2027F, 2032F, Growth And Market Share Comparison, By Country
  • 15.5. Western Europe, Biologics Market Metrics
    • 15.5.1. Per Capita Average Biologics Expenditure, 2017-2027, Western Europe Countries
    • 15.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2022, Western Europe Countries
    • 15.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2022, Western Europe Countries
  • 15.6. Western Europe Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 15.7. Western Europe Biologics Market: Country Analysis
    • 15.7.1. Austria Biologics Market
      • 15.7.1.1. Austria Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 15.7.2. Belgium Biologics Market
      • 15.7.2.1. Belgium Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 15.7.3. Denmark Biologics Market
      • 15.7.3.1. Denmark Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 15.7.4. Finland Biologics Market
      • 15.7.4.1. Finland Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 15.7.5. France Biologics Market
      • 15.7.5.1. France Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
      • 15.7.5.2. France Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 15.7.6. Germany Biologics Market
      • 15.7.6.1. Germany Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
      • 15.7.6.2. Germany Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 15.7.7. Ireland Biologics Market
      • 15.7.7.1. Ireland Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 15.7.8. Italy Biologics Market
      • 15.7.8.1. Italy Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 15.7.9. Netherlands Biologics Market
      • 15.7.9.1. Netherlands Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 15.7.10. Norway Biologics Market
      • 15.7.10.1. Norway Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 15.7.11. Portugal Biologics Market
      • 15.7.11.1. Portugal Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 15.7.12. Spain Biologics Market
      • 15.7.12.1. Spain Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 15.7.13. Sweden Biologics Market
      • 15.7.13.1. Sweden Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 15.7.15. Switzerland Biologics Market
      • 15.7.15.1. Switzerland Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 15.7.15. UK Biologics Market
      • 15.7.15.1. UK Biologics Market2017-2022, 2022-2027F, 2032F, Value ($ Billion)
      • 15.7.15.2. UK Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)

16. Eastern Europe Biologics Market

  • 16.1. Eastern Europe Biologics Market Overview
  • 16.2. Eastern Europe, Biologics Market, 2022, By Country, Value ($ Billion)
  • 16.3. Eastern Europe, Biologics Market, 2017-2022, 2022-2027F, 2032F, Historic And Forecast, By Country
  • 16.4. Eastern Europe, Biologics Market, 2017-2022, 2022-2027F, 2032F, Growth And Market Share Comparison, By Country
  • 16.5. Eastern Europe, Biologics Market Metrics
    • 16.5.1. Per Capita Average Biologics Expenditure, 2017-2027, Eastern Europe Countries
    • 16.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2022, Eastern Europe Countries
    • 16.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2022, Eastern Europe Countries
  • 16.6. Eastern Europe Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 16.7. Eastern Europe Biologics Market: Country Analysis
    • 16.7.1. Czech Republic Biologics Market,
      • 16.7.1.1. Czech Republic Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 16.7.2. Poland Biologics Market
      • 16.7.2.1. Poland Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 16.7.3. Romania Biologics Market
      • 16.7.3.1. Romania Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 16.7.4. Russia Biologics Market
      • 16.7.4.1. Russia Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
      • 16.7.4.2. Russia Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 16.7.5. Ukraine Biologics Market
      • 16.7.5.1. Ukraine Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)

17. North America Biologics Market

  • 17.1. North America Biologics Market Overview
  • 17.2. North America, Biologics Market, 2022, By Country, Value ($ Billion)
  • 17.3. North America, Biologics Market, 2017-2022, 2022-2027F, 2032F, Historic And Forecast, By Country
  • 17.4. North America, Biologics Market, 2017-2022, 2022-2027F, 2032F, Growth And Market Share Comparison, By Country
  • 17.5. North America, Biologics Market Metrics
    • 17.5.1. Per Capita Average Biologics Expenditure, 2017-2027, North America Countries
    • 17.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2022, North America Countries
    • 17.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2022, North America Countries
  • 17.6. North America Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 17.7. North America Biologics Market: Country Analysis
    • 17.7.1. Canada Biologics Market
      • 17.7.1.1. Canada Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 17.7.2. Mexico Biologics Market
      • 17.7.2.1. Mexico Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 17.7.3. USA Biologics Market
      • 17.7.3.1. USA Biologics Market Overview
      • 17.7.3.2. USA Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
      • 17.7.3.3. USA Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)

18. South America Biologics Market

  • 18.1. South America Biologics Market Overview
  • 18.2. South America, Biologics Market, 2022, By Country, Value ($ Billion)
  • 18.3. South America, Biologics Market, 2017-2022, 2022-2027F, 2032F, Historic And Forecast, By Country
  • 18.4. South America, Biologics Market, 2017-2022, 2022-2027F, 2032F, Growth And Market Share Comparison, By Country
  • 18.5. South America, Biologics Market Metrics
    • 18.5.1. Per Capita Average Biologics Expenditure, 2017-2027, South America Countries
    • 18.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2022, South America Countries
    • 18.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2022, South America Countries
  • 18.6. South America Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 18.7. South America Biologics Market: Country Analysis
    • 18.7.1. Argentina Biologics Market
      • 18.7.1.1. Argentina Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 18.7.2. Brazil Biologics Market
      • 18.7.1.1. Brazil Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
      • 18.7.2.2. Brazil Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 18.7.3. Chile Biologics Market
      • 18.7.3.1. Chile Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 18.7.4. Colombia Biologics Market
      • 18.7.4.1. Colombia Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 18.7.5. Peru Biologics Market
      • 18.7.5.1. Peru Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 18.7.6. Venezuela Biologics Market
      • 18.7.6.1. Venezuela Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)

19. Middle East Biologics Market

  • 19.1. Middle East Biologics Market Overview
  • 19.2. Middle East, Biologics Market, 2022, By Country, Value ($ Billion)
  • 19.3. Middle East, Biologics Market, 2017-2022, 2022-2027F, 2032F, Historic And Forecast, By Country
  • 19.4. Middle East, Biologics Market, 2017-2022, 2022-2027F, 2032F, Growth And Market Share Comparison, By Country
  • 19.5. Middle East, Biologics Market Metrics
    • 19.5.1. Per Capita Average Biologics Expenditure, 2017-2027, Middle East Countries
    • 19.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2022, Middle East Countries
    • 19.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2022, Middle East Countries
  • 19.6. Middle East Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 19.7. Middle East Biologics Market: Country Analysis
    • 19.7.1. Saudi Arabia Biologics Market
      • 19.7.1.1. Saudi Arabia Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 19.7.2. Israel Biologics Market
      • 19.7.2.1. Israel Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 19.7.3. Turkey Biologics Market
      • 19.7.3.1. Turkey Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 19.7.4. UAE Biologics Market
      • 19.7.4.1. UAE Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)

20. Africa Biologics Market

  • 20.1. Africa Biologics Market Overview
  • 20.2. Africa, Biologics Market, 2022, By Country, Value ($ Billion)
  • 20.3. Africa, Biologics Market, 2017-2022, 2022-2027F, 2032F, Historic And Forecast, By Country
  • 20.4. Africa, Biologics Market, 2017-2022, 2022-2027F, 2032F, Growth And Market Share Comparison, By Country
  • 20.5. Africa, Biologics Market Metrics
    • 20.5.1. Per Capita Average Biologics Expenditure, 2017-2027, Africa Countries
    • 20.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2022, Africa Countries
    • 20.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2022, Africa Countries
  • 20.6. Africa Biologics Market, Segmentation By Type, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
  • 20.7. Africa Biologics Market: Country Analysis
    • 20.7.1. Egypt Biologics Market
      • 20.7.1.1. Egypt Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 20.7.2. Nigeria Biologics Market
      • 20.7.2.1. Nigeria Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)
    • 20.7.3. South Africa Biologics Market
      • 20.7.3.1. South Africa Biologics Market, 2017-2022, 2022-2027F, 2032F, Value ($ Billion)

21. Biologics Market Competitive Landscape

  • 21.1. Competitive Market Overview
  • 21.2. Market Shares
  • 21.3. Company Profiles
    • 21.3.1. AbbVie
      • 21.3.1.1. Company Overview
      • 21.3.1.2. Products And Services
      • 21.3.1.3. Strategy
      • 21.3.1.4. Financial Performance
    • 21.3.2. Johnson & Johnson
      • 21.3.2.1. Company Overview
      • 21.3.2.2. Products And Services
      • 21.3.2.3. Strategy
      • 21.3.2.4. Financial Performance
    • 21.3.3. Amgen
      • 21.3.3.1. Company Overview
      • 21.3.3.2. Products And Services
      • 21.3.3.3. Strategy
      • 21.3.3.4. Financial Performance
    • 21.3.4. Sanofi S.A
      • 21.3.4.1. Company Overview
      • 21.3.4.2. Products And Services
      • 21.3.4.3. Strategy
      • 21.3.4.4. Financial Performance
    • 21.3.5. F. Hoffmann-La Roche Ltd
      • 21.3.5.1. Company Overview
      • 21.3.5.2. Products And Services
      • 21.3.5.3. Strategy
      • 21.3.5.4. Financial Performance

22. Key Mergers And Acquisitions In The Biologics Market

23. Market Background: Pharmaceuticals Market

  • 23.1. Pharmaceuticals Market Characteristics
  • 23.2. Pharmaceuticals Market Historic and Forecast, 2017-2022, 2022-2027F, 2032F Growth, By Segment, Value ($ Billion), Global
  • 23.3. Global Pharmaceuticals Market, 2022, By Region, Value ($ Billion)
  • 23.4. Global Pharmaceuticals Market, 2017-2022, 2022-2027F, 2032F, Historic And Forecast, By Region
  • 23.5. Global Pharmaceuticals Market, 2017-2022, 2022-2027F, 2032F, Segmentation By Type, Value ($ Billion)

24. Recommendations

  • 24.1. Global Biologics Market In 2027- Growth Countries
  • 24.2. Global Biologics Market In 2027- Growth Segments
  • 24.3. Global Biologics Market In 2027- Growth Strategies

25. Appendix

  • 25.1. NAICS Definitions Of Industry Covered In This Report
  • 25.2. Abbreviations
  • 25.3. Currencies
  • 25.4. Historic And Forecast Inflation Rates
  • 25.5. Research Inquiries
  • 25.6. The Business Research Company
  • 25.7. Copyright And Disclaimer
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제